Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
161 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 62578 |
552 | 2 | TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS | 15141 |
7207 | 1 | FULVESTRANT//ENDOCRINE RESISTANCE//ENDOCRINE THERAPY | 1421 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | FULVESTRANT | authKW | 2030628 | 11% | 59% | 154 |
2 | ENDOCRINE RESISTANCE | authKW | 889034 | 6% | 48% | 84 |
3 | ENDOCRINE THERAPY | authKW | 368074 | 8% | 15% | 111 |
4 | FASLODEX | authKW | 364747 | 2% | 66% | 25 |
5 | ADVANCED BREAST CANCER | authKW | 243979 | 5% | 16% | 71 |
6 | TENOVUS CANC | address | 229956 | 3% | 28% | 37 |
7 | TAMOXIFEN RESISTANCE | authKW | 190563 | 3% | 23% | 38 |
8 | HLTH SCI IL 1 | address | 157845 | 1% | 65% | 11 |
9 | HORMONE RECEPTOR POSITIVE | authKW | 130781 | 1% | 35% | 17 |
10 | ESTROGEN RECEPTOR | authKW | 112523 | 13% | 3% | 187 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 25111 | 68% | 0% | 967 |
2 | Endocrinology & Metabolism | 1905 | 15% | 0% | 213 |
3 | Cell Biology | 361 | 10% | 0% | 143 |
4 | Obstetrics & Gynecology | 277 | 5% | 0% | 71 |
5 | Biochemistry & Molecular Biology | 183 | 14% | 0% | 197 |
6 | Pharmacology & Pharmacy | 43 | 6% | 0% | 85 |
7 | Medicine, Research & Experimental | 34 | 3% | 0% | 44 |
8 | Genetics & Heredity | 16 | 3% | 0% | 42 |
9 | Chemistry, Medicinal | 12 | 2% | 0% | 24 |
10 | Theater | 1 | 0% | 0% | 1 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | TENOVUS CANC | 229956 | 3% | 28% | 37 |
2 | HLTH SCI IL 1 | 157845 | 1% | 65% | 11 |
3 | BREAST CARE SUPPORT GRP | 110888 | 0% | 100% | 5 |
4 | TUMOR ENDOCRINOL | 101361 | 1% | 29% | 16 |
5 | NK BASILE CANC BREAST EXCELLENCE | 88711 | 0% | 100% | 4 |
6 | MOL FUNCT DYNAM | 71844 | 1% | 36% | 9 |
7 | BREAST CANC GRP | 67563 | 1% | 19% | 16 |
8 | LESTER SUE SMITH BREAST | 63512 | 2% | 10% | 30 |
9 | CELL DEATH METAB | 57186 | 0% | 37% | 7 |
10 | BREAST CANC CLIN PROGRAM | 44355 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ENDOCRINE-RELATED CANCER | 38875 | 4% | 3% | 55 |
2 | BREAST CANCER RESEARCH AND TREATMENT | 36633 | 8% | 1% | 111 |
3 | CLINICAL BREAST CANCER | 14315 | 2% | 3% | 23 |
4 | BREAST CANCER RESEARCH | 12784 | 3% | 2% | 36 |
5 | BREAST | 9611 | 2% | 1% | 33 |
6 | CLINICAL CANCER RESEARCH | 7231 | 5% | 0% | 71 |
7 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 6534 | 4% | 1% | 52 |
8 | BREAST CARE | 4504 | 1% | 2% | 11 |
9 | MOLECULAR ENDOCRINOLOGY | 3273 | 2% | 1% | 29 |
10 | CANCER TREATMENT REVIEWS | 2794 | 1% | 1% | 16 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FULVESTRANT | 2030628 | 11% | 59% | 154 | Search FULVESTRANT | Search FULVESTRANT |
2 | ENDOCRINE RESISTANCE | 889034 | 6% | 48% | 84 | Search ENDOCRINE+RESISTANCE | Search ENDOCRINE+RESISTANCE |
3 | ENDOCRINE THERAPY | 368074 | 8% | 15% | 111 | Search ENDOCRINE+THERAPY | Search ENDOCRINE+THERAPY |
4 | FASLODEX | 364747 | 2% | 66% | 25 | Search FASLODEX | Search FASLODEX |
5 | ADVANCED BREAST CANCER | 243979 | 5% | 16% | 71 | Search ADVANCED+BREAST+CANCER | Search ADVANCED+BREAST+CANCER |
6 | TAMOXIFEN RESISTANCE | 190563 | 3% | 23% | 38 | Search TAMOXIFEN+RESISTANCE | Search TAMOXIFEN+RESISTANCE |
7 | HORMONE RECEPTOR POSITIVE | 130781 | 1% | 35% | 17 | Search HORMONE+RECEPTOR+POSITIVE | Search HORMONE+RECEPTOR+POSITIVE |
8 | ESTROGEN RECEPTOR | 112523 | 13% | 3% | 187 | Search ESTROGEN+RECEPTOR | Search ESTROGEN+RECEPTOR |
9 | ESR1 MUTATIONS | 110888 | 0% | 100% | 5 | Search ESR1+MUTATIONS | Search ESR1+MUTATIONS |
10 | EVEROLIMUS | 109818 | 6% | 6% | 82 | Search EVEROLIMUS | Search EVEROLIMUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |